The global human organochips market is expected to grow at a CAGR of XX% during the forecast period. The market is driven by factors such as increasing demand for organochips in pharmaceutical and biotechnology applications, growing number of research institutes and academic institutions that are using organochips for research purposes, and increasing demand for cosmetics industry end users.
The global human organochips market has been segmented on the basis of type into live-chips, kidney-chips, intestino-chips, lungo-chips, hearo-chip organs. The live chips segment accounted for the largest share in 2018 owing to its wide application in pharmaceutical and biotechnology applications. The kidney chips segment is expected to grow at a higher CAGR during the forecast period due to its wide application in academic & research institutes as well as cosmetology industry end users.
North America accounted for the largest share of the global human organochip market in 2018 owing to high adoption rates among pharma companies and biotech firms which are driving growth across North America region. Europe followed North America with significant contribution from pharma companies which are driving growth across Europe region. Asia Pacific is expected to witness significant growth during 2019 - 2030 due to rising adoption rates among pharma companies and biotech firms which are driving growth across Asia Pacific region.
Some Of The Growth Factors Of This Market:
- The Human Organs-on-Chips market is expected to witness significant growth in the coming years due to its ability to mimic human physiology and provide accurate results for drug testing, which are not possible with traditional methods such as animal models or cell cultures.
- Increasing demand for personalized medicine and growing healthcare expenditure in emerging economies are some of the factors driving the growth of this market during the forecast period (2017 - 2025) 4) Increasing demand for personalized medicine and growing healthcare expenditure in emerging economies are some of the factors driving the growth of this market during the forecast period (2017 - 2025).
Industry Growth Insights published a new data on “Human Organs-on-Chips Market”. The research report is titled “Human Organs-on-Chips Market research by Types (Liver-on-a-chip, Kidney-on-a-chip, Intestine-on-a-chip, Lung-on-a-chip, Heart-on-a-chip, Other Organs), By Applications (Pharmaceutical & Biotechnology, Academic & Research Institutes, Cosmetics Industry, Other End Users), By Players/Companies Emulate, TissUse GmbH, Hesperos, CN Bio Innovations, Tara Biosystems, Draper Laboratory, Mimetas, Nortis Bio, Micronit, Kirkstall, Cherry Biotech, Else Kooi Lab”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Human Organs-on-Chips Market Research Report
By Type
Liver-on-a-chip, Kidney-on-a-chip, Intestine-on-a-chip, Lung-on-a-chip, Heart-on-a-chip, Other Organs
By Application
Pharmaceutical & Biotechnology, Academic & Research Institutes, Cosmetics Industry, Other End Users
By Companies
Emulate, TissUse GmbH, Hesperos, CN Bio Innovations, Tara Biosystems, Draper Laboratory, Mimetas, Nortis Bio, Micronit, Kirkstall, Cherry Biotech, Else Kooi Lab
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Human Organs-on-Chips Market Report Segments:
The global Human Organs-on-Chips market is segmented on the basis of:
Types
Liver-on-a-chip, Kidney-on-a-chip, Intestine-on-a-chip, Lung-on-a-chip, Heart-on-a-chip, Other Organs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical & Biotechnology, Academic & Research Institutes, Cosmetics Industry, Other End Users
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Emulate
- TissUse GmbH
- Hesperos
- CN Bio Innovations
- Tara Biosystems
- Draper Laboratory
- Mimetas
- Nortis Bio
- Micronit
- Kirkstall
- Cherry Biotech
- Else Kooi Lab
Highlights of The Human Organs-on-Chips Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Liver-on-a-chip
- Kidney-on-a-chip
- Intestine-on-a-chip
- Lung-on-a-chip
- Heart-on-a-chip
- Other Organs
- By Application:
- Pharmaceutical & Biotechnology
- Academic & Research Institutes
- Cosmetics Industry
- Other End Users
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Human Organs-on-Chips Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Human organs-on-chips are medical devices that mimic the function of human organs. They can be used to study how organ functions work and to test new treatments for diseases.
Some of the key players operating in the human organs-on-chips market are Emulate, TissUse GmbH, Hesperos, CN Bio Innovations, Tara Biosystems, Draper Laboratory, Mimetas, Nortis Bio, Micronit, Kirkstall, Cherry Biotech, Else Kooi Lab.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Human Organs-on-Chips Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Human Organs-on-Chips Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Human Organs-on-Chips Market - Supply Chain
4.5. Global Human Organs-on-Chips Market Forecast
4.5.1. Human Organs-on-Chips Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Human Organs-on-Chips Market Size (000 Units) and Y-o-Y Growth
4.5.3. Human Organs-on-Chips Market Absolute $ Opportunity
5. Global Human Organs-on-Chips Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Human Organs-on-Chips Market Size and Volume Forecast by Type
5.3.1. Liver-on-a-chip
5.3.2. Kidney-on-a-chip
5.3.3. Intestine-on-a-chip
5.3.4. Lung-on-a-chip
5.3.5. Heart-on-a-chip
5.3.6. Other Organs
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Human Organs-on-Chips Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Human Organs-on-Chips Market Size and Volume Forecast by Application
6.3.1. Pharmaceutical & Biotechnology
6.3.2. Academic & Research Institutes
6.3.3. Cosmetics Industry
6.3.4. Other End Users
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Human Organs-on-Chips Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Human Organs-on-Chips Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Human Organs-on-Chips Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Human Organs-on-Chips Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Human Organs-on-Chips Demand Share Forecast, 2019-2026
9. North America Human Organs-on-Chips Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Human Organs-on-Chips Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Human Organs-on-Chips Market Size and Volume Forecast by Application
9.4.1. Pharmaceutical & Biotechnology
9.4.2. Academic & Research Institutes
9.4.3. Cosmetics Industry
9.4.4. Other End Users
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Human Organs-on-Chips Market Size and Volume Forecast by Type
9.7.1. Liver-on-a-chip
9.7.2. Kidney-on-a-chip
9.7.3. Intestine-on-a-chip
9.7.4. Lung-on-a-chip
9.7.5. Heart-on-a-chip
9.7.6. Other Organs
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Human Organs-on-Chips Demand Share Forecast, 2019-2026
10. Latin America Human Organs-on-Chips Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Human Organs-on-Chips Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Human Organs-on-Chips Market Size and Volume Forecast by Application
10.4.1. Pharmaceutical & Biotechnology
10.4.2. Academic & Research Institutes
10.4.3. Cosmetics Industry
10.4.4. Other End Users
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Human Organs-on-Chips Market Size and Volume Forecast by Type
10.7.1. Liver-on-a-chip
10.7.2. Kidney-on-a-chip
10.7.3. Intestine-on-a-chip
10.7.4. Lung-on-a-chip
10.7.5. Heart-on-a-chip
10.7.6. Other Organs
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Human Organs-on-Chips Demand Share Forecast, 2019-2026
11. Europe Human Organs-on-Chips Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Human Organs-on-Chips Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Human Organs-on-Chips Market Size and Volume Forecast by Application
11.4.1. Pharmaceutical & Biotechnology
11.4.2. Academic & Research Institutes
11.4.3. Cosmetics Industry
11.4.4. Other End Users
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Human Organs-on-Chips Market Size and Volume Forecast by Type
11.7.1. Liver-on-a-chip
11.7.2. Kidney-on-a-chip
11.7.3. Intestine-on-a-chip
11.7.4. Lung-on-a-chip
11.7.5. Heart-on-a-chip
11.7.6. Other Organs
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Human Organs-on-Chips Demand Share, 2019-2026
12. Asia Pacific Human Organs-on-Chips Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Human Organs-on-Chips Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Human Organs-on-Chips Market Size and Volume Forecast by Application
12.4.1. Pharmaceutical & Biotechnology
12.4.2. Academic & Research Institutes
12.4.3. Cosmetics Industry
12.4.4. Other End Users
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Human Organs-on-Chips Market Size and Volume Forecast by Type
12.7.1. Liver-on-a-chip
12.7.2. Kidney-on-a-chip
12.7.3. Intestine-on-a-chip
12.7.4. Lung-on-a-chip
12.7.5. Heart-on-a-chip
12.7.6. Other Organs
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Human Organs-on-Chips Demand Share, 2019-2026
13. Middle East & Africa Human Organs-on-Chips Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Human Organs-on-Chips Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Human Organs-on-Chips Market Size and Volume Forecast by Application
13.4.1. Pharmaceutical & Biotechnology
13.4.2. Academic & Research Institutes
13.4.3. Cosmetics Industry
13.4.4. Other End Users
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Human Organs-on-Chips Market Size and Volume Forecast by Type
13.7.1. Liver-on-a-chip
13.7.2. Kidney-on-a-chip
13.7.3. Intestine-on-a-chip
13.7.4. Lung-on-a-chip
13.7.5. Heart-on-a-chip
13.7.6. Other Organs
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Human Organs-on-Chips Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Human Organs-on-Chips Market: Market Share Analysis
14.2. Human Organs-on-Chips Distributors and Customers
14.3. Human Organs-on-Chips Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Emulate
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. TissUse GmbH
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Hesperos
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. CN Bio Innovations
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Tara Biosystems
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Draper Laboratory
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Mimetas
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Nortis Bio
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Micronit
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Kirkstall
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Cherry Biotech
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Else Kooi Lab
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
